 |
|
||||||||||
 |
|||||||||||
|
|||||||||||
|
|||||||||||||||||||
|
|
|||||||||||||||||||
|
Year : 2020 | Volume: 35 | Issue Number: 4 | Page: 299-304 ORIGINAL ARTICLEHealth-related quality-of-life outcomes with actinium-225-prostate-specific membrane antigen-617 therapy in patients with heavily pretreated metastatic castration-resistant prostate cancer Satapathy Swayamjeet, Mittal Bhagwant Rai, Sood Ashwani, Das Chandan Krushna, Singh Shrawan Kumar, Mavuduru Ravimohan Suryanarayan, Bora Girdhar Singh
|
|
||||||||||||||||||||||||||||||
|
|||||||||
Article
Access Statistics
